1. Home
  2. OKYO vs PCLA Comparison

OKYO vs PCLA Comparison

Compare OKYO & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

SELL

Current Price

$1.09

Market Cap

78.2M

Sector

Health Care

ML Signal

SELL

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

N/A

Current Price

$5.84

Market Cap

78.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
OKYO
PCLA
Founded
2007
2008
Country
United Kingdom
Japan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
78.2M
78.7M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
OKYO
PCLA
Price
$1.09
$5.84
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $8.33
N/A
AVG Volume (30 Days)
282.3K
★ 1.0M
Earning Date
07-20-2026
02-12-2027
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.12
52 Week High
$3.20
$19.61

Technical Indicators

Market Signals
Indicator
OKYO
PCLA
Relative Strength Index (RSI) 33.79 44.34
Support Level N/A $4.21
Resistance Level $1.70 $6.95
Average True Range (ATR) 0.13 0.42
MACD -0.03 -0.07
Stochastic Oscillator 20.23 6.91

Price Performance

Historical Comparison
OKYO
PCLA

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: